Drugs & Targets FDA Grants Approvals to Tecentriq, Opdivo, Imbruvica, Lenvima June 02, 2016Vol.- No.-
Drugs & Targets ProNAi Therapeutics and Carna Biosciences to commercialize AS-141 May 27, 2016Vol.42 No.21
Drugs & Targets CHMP Issues Positive Opinion For Kyprolis in Multiple Myeloma May 27, 2016Vol.42 No.21
Drugs & Targets Health Canada approves Imbruvica in Waldenström’s macroglobulinemia May 13, 2016Vol.42 No.19
Drugs & Targets Health Canada grants conditional approval to Ibrance in breast cancer May 13, 2016Vol.42 No.19
